Cruciate Ligament Diagnosis and Treatment Market

A ligament is a band of tissue that holds the bones together, keeping the knee stable. Primarily these ligaments are broadly classified into cruciate ligament and collateral ligament. Further, these are divided into four primary ligaments, namely, Anterior Cruciate Ligament (ACL), Posterior Cruciate Ligament (PCL), Medial Collateral Ligament (MCL), and Lateral Collateral Ligament (LCL). The cruciate ligaments, i.e., the PCL and ACL are crossed ligaments that stabilize the joint while allowing a very large range of motion. Knee injuries are usually the most common musculoskeletal traumas among people, where the Anterior Cruciate Ligament (ACL) injury is one of the utmost frequent occurring knee injuries. Surgical reconstruction is the standard gold treatment for treating knee injuries. Increasing incidences of sports-related injuries have become a leading cause of soft tissue injuries worldwide. Athletes are most likely to injure the ACLs disabling complete stretching of their legs. A type of surgery that involves reconstruction of the ligament is known as ACL reconstruction that lies in the center of one?s knee with a graft.
Cruciate Ligament Diagnosis and Treatment Market contains market size and forecasts of Cruciate Ligament Diagnosis and Treatment in Global, including the following market information:
Global Cruciate Ligament Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cruciate Ligament Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Posterior Cruciate Ligament (PCL) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cruciate Ligament Diagnosis and Treatment include Stryker, Arthrex, Zimmer Biomet, DePuy Synthes, Conmed, Smith & Nephew, 3M, DJO Global and Breg, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cruciate Ligament Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cruciate Ligament Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cruciate Ligament Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)
Posterior Cruciate Ligament (PCL)
Anterior Cruciate Ligament (ACL)
Global Cruciate Ligament Diagnosis and Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cruciate Ligament Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Orthopedic Clinics
Ambulatory Surgical Center (ASC)
Others
Global Cruciate Ligament Diagnosis and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cruciate Ligament Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cruciate Ligament Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cruciate Ligament Diagnosis and Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Stryker
Arthrex
Zimmer Biomet
DePuy Synthes
Conmed
Smith & Nephew
3M
DJO Global
Breg
Bauerfeind AG
DeRoyal Industries
BSN Medical GmbH